CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

Aim. To compare cost-effectiveness of the use of direct factor Xa inhibitors rivaroxaban and apixaban in patients with non-valvular atrial fibrillation (AF) and to assess the impact of the both therapies on the healthcare budget of Russian Federation.Material and methods. Pharmacoeconomic analysis w...

Full description

Bibliographic Details
Main Authors: S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2017-03-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
pharmacoeconomic analysis
atrial fibrillation
stroke
rivaroxaban
apixaban
Online Access:https://www.rpcardio.com/jour/article/view/1414

Internet

https://www.rpcardio.com/jour/article/view/1414

Similar Items